Ru-catalyzed Asymmetric Hydrogenation Research Articles

Scalable Synthesis of ABBV-105 Enabled by Suzuki Coupling with Low Pd Loading, Ru-Catalyzed Asymmetric Hydrogenation, and Acylation Using Impinging Jet

Scalable Synthesis of ABBV-105 Enabled by Suzuki Coupling with Low Pd Loading, Ru-Catalyzed Asymmetric Hydrogenation, and Acylation Using Impinging Jet

Ru-catalyzed asymmetric hydrogenation of α,β-unsaturated ketones via a hydrogenation/isomerization cascade.

Ru-catalyzed asymmetric hydrogenation of α-substituted α,β-unsaturated ketones has been developed for the enantioselective synthesis of chiral α-substituted secondary alcohols with high diastereo- and enantioselectivities (up to >99 : 1 dr, 98% ee). Mechanistic experiments suggest that the reaction proceeds via a Ru-catalyzed asymmetric hydrogenation of the CO bond in concert with a base-promoted allylic alcohol isomerization, and the final stereoselectivities were controlled by a DKR process during the asymmetric hydrogenation of the ketone intermediate.

Asymmetric Synthesis of Chiral Seven-Membered NHCs, Their Transition-Metal Complexes and Application in Asymmetric ­Catalysis

AbstractA series of new chiral seven-membered NHCs were synthesized via Ru-catalyzed asymmetric hydrogenation reactions as the key step. Transition metal such as Rh, Ir and Au can coordinate to the developed NHCs. The crystal structures of the chiral seven-membered NHCs and their transition-metal complexes show a nonplanar framework with torsional twist. Furthermore, the chiral NHCs were applied in asymmetric hydrosilylation reactions, and the corresponding product was obtained with >95% yield and up to 83% ee.

Ruthenium-Catalyzed Enantioselective Hydrogenation of 9-Phenanthrols.

The enantioselective hydrogenation of arenols to corresponding chiral cyclic alcohols remains a challenge because of their aromaticity and the difficulty in controlling the regio-, chemo-, and stereoselectivity. In this work, the first highly efficient ruthenium-catalyzed enantioselective hydrogenation of 9-phenanthrols has been successfully realized under mild conditions via trapping the unstable keto tautomers. The method provides a facile access to a range of chiral 9,10-dihydrophenanthren-9-ols with up to 98 % yield and >99 % ee. The hydrogenation pathway includes base-promoted tautomerization of 9-phenanthrols and Ru-catalyzed asymmetric hydrogenation of the in situ generated unstable keto tautomers.

Highly efficient and enantioselective synthesis of β-heteroaryl amino alcohols via Ru-catalyzed asymmetric hydrogenation.

Chiral β-heteroaryl amino alcohols are key fragments of many bioactive compounds and antibiotics, and the development of efficient synthetic methods for these compounds is of great value. The highly enantioselective hydrogenation of α-N-heteroaryl ketones was realized with a ruthenium-diphosphine-diamine catalyst, providing the corresponding chiral β-heteroaryl amino alcohols with up to 99% yield and up to >99% ee. The synthetic utilities of the current reaction were demonstrated by gram-scale synthesis of key intermediates of Sertaconazole and Cenobamate.

Primary trifluoroborate-iminiums enable facile access to chiral α-aminoboronic acids via Ru-catalyzed asymmetric hydrogenation and simple hydrolysis of the trifluoroborate moiety.

This work describes the first preparation and application of primary trifluoroborate-iminiums (pTIMs) as a new, easily accessible and valuable class of organoboron derivatives. An array of structurally diverse pTIMs was prepared from potassium acyltrifluoroborates in excellent yields. Highly efficient and enantioselective [(R,R)-TethTsDpen-RuCl] complex-catalyzed hydrogenation of pTIMs provided direct access to chiral primary trifluoroborate-ammoniums (pTAMs). Moreover, facile synthesis of a series of structurally diverse chiral α-aminoboronic acids from chiral pTAMs was accomplished through novel, operationally simple and efficient conversion using hexamethyldisiloxane/aqueous HCl. Using no chromatography at any point, this work allowed easy access to chiral α-aminoboronic acids, as exemplified by the synthesis of optically pure anti-cancer drugs bortezomib and ixazomib.

Ruthenium-catalyzed enantioselective hydrogenation of quinoxalinones and quinazolinones

An efficient Ru-catalyzed asymmetric hydrogenation of quinoxalinone and quinazolinone derivatives has been developed, providing a facile access to chiral dihydroquinoxalinones and dihydroquinazolinones with excellent enantioselectivities.

Straightforward Synthesis of Chiral Terpenoid Building Blocks by Ru-Catalyzed Enantioselective Hydrogenation.

Starting from commercially available (R)- and (S)-β-citronellol, two strategies were designed to synthesize all four stereoisomers of 2,6-dimethyloctane monoterpene chirons in four or five steps in 32-47% overall yield. The desired fragments were obtained by a key Ru-catalyzed asymmetric olefin hydrogenation step under moderate temperature (50 °C), pressure (4 bar), and low catalyst loadings (0.5 mol %) under optimized conditions. Screening of commercially available catalysts highlighted the key role of DM-SEGPHOS as an economically advantageous alternative to commonly used H8-BINAP for equal performances. These results open new possibilities for versatile and scalable syntheses of these useful building blocks.

Synthesis and characterization of a high-purity chiral 5,5'-disulfonato-BINAP ligand and its application in asymmetric hydrogenation of β-keto esters

Abstract 2,2′-Bis(diphenylphosphino)-1,1′-binaphthyl (BINAP) is a widely used chiral phosphine ligand, and the sulfonated BINAP is one of the important water-soluble BINAP derivatives. In this article, we report an improved oleum sulfonation method for the synthesis of the high-purity 5,5′-disulfonato-(S)-BINAP ligand with an industrially acceptable high yield. By optimizing the sulfonation conditions and improving the workup process, the yield of 5,5′-disulfonated products was enhanced to 73 %. Furthermore, an acetonitrile extraction protocol was developed for the purification of sulfonated products by efficiently removing phosphine oxides, by which the content of phosphine oxide can be controlled below 3 %. The structure of 5,5′-disulfonato-(S)-BINAP was characterized with the elemental analysis, FT-IR, 1H NMR, 13C NMR, 31P NMR, 1H-1H COSY, 1H-13C HSQC, 1H-13C HMBC, and HR-MS, which unambiguously confirmed that the sulfo groups are introduced at the 5,5′-position of the binaphthyl ring skeleton in (S)-BINAP. The prepared high-purity 5,5′-disulfonato-(S)-BINAP was evaluated in the Ru-catalyzed asymmetric hydrogenation of β-keto esters, which exhibited high catalytic activity, enantioselectivity and excellent catalytic stability.

Ruthenium-catalyzed hydrogenation of aromatic ketones using chiral diamine and monodentate achiral phosphine ligands

The Ru-catalyzed asymmetric hydrogenation of ketones with chiral diamine and monodentate achiral phosphine has been developed. A wide range of ketones were hydrogenated to afford the corresponding chiral secondary alcohols in good to excellent enantioselectivities (up to 98.1% ee). In addition, an appropriate mechanism for the asymmetric hydrogenation was proposed and verified by NMR spectroscopy.

Asymmetric Hydrogenation of Dibenzo[c,e]azepine Derivatives with Chiral Cationic Ruthenium Diamine Catalysts.

An efficient Ru-catalyzed asymmetric hydrogenation of dibenzo[c,e]azepines is reported. A series of seven-membered cyclic amines were obtained with moderate to excellent enantioselectivity. The catalyst counteranion played an important role in achieving high-level chiral induction. Moreover, a one-pot synthesis of chiral 6,7-dihydro-5H-dibenz[c,e]azepines via two-step reductive amination was also developed.

Synthesis of a CGRP Receptor Antagonist via an Asymmetric Synthesis of 3-Fluoro-4-aminopiperidine.

A practical and efficient enantioselective synthesis of the calcitonin gene-related peptide receptor antagonist 1 has been developed. The key structural component of the active pharmaceutical ingredient is a syn-1,2-amino-fluoropiperidine 4. Two approaches were developed to synthesize this important pharmacophore. Initially, Ru-catalyzed asymmetric hydrogenation of fluoride-substituted enamide 8 enabled the synthesis of sufficient quantities of compound 1 to support early preclinical studies. Subsequently, a novel, cost-effective route to this intermediate was developed utilizing a dynamic kinetic asymmetric transamination of ketone 9. This synthesis also features a robust Ullmann coupling to install a bis-aryl ether using a soluble Cu(I) catalyst. Finally, an enzymatic desymmetrization of meso-diester 7 was exploited for the construction of the γ-lactam moiety in 1.

Enantioselective synthesis of tunable chiral pyridine–aminophosphine ligands and their applications in asymmetric hydrogenation

A small library of tunable chiral pyridine-aminophosphine ligands were enantioselectively synthesized based on chiral 2-(pyridin-2-yl)-substituted 1,2,3,4-tetrahydroquinoline scaffolds, which were obtained in high yields and with excellent enantioselectivities via ruthenium-catalyzed asymmetric hydrogenation of 2-(pyridin-2-yl)quinolines. The protocol features a wide substrate scope and mild reaction conditions, enabling scalable synthesis. These chiral P,N ligands were successfully applied in the Ir-catalyzed asymmetric hydrogenation of benchmark olefins and challenging seven-membered cyclic imines including benzazepines and benzodiazepines. Excellent enantio- and diastereoselectivity (up to 99% ee and >20 : 1 dr), and/or unprecedented chemoselectivity were obtained in the asymmetric hydrogenation of 2,4-diaryl-3H-benzo[b]azepines and 2,4-diaryl-3H-benzo[b][1,4]diazepines.

Mechanistic Study of the Ru-Catalyzed Asymmetric Hydrogenation of Nonchelatable and Chelatabletert-Alkyl Ketones Using the Linear Tridentate sp3P/sp3NH/sp2N-Combined Ligand PN(H)N: RuNH- and RuNK-Involved Dual Catalytic Cycle

The linear tridentate sp3P/sp3NH/sp2N ligand PN(H)N ((R)-2′-(diphenylphosphino)-N-(pyridin-2-ylmethyl)[1,1′-binaphthalen]-2-amine) exclusively forms fac-[Ru(PN(H)N)(dmso)3](BF4)2 over the mer isome...

Asymmetric Synthesis of Akt Kinase Inhibitor Ipatasertib.

A highly efficient asymmetric synthesis of the Akt kinase inhibitor ipatasertib (1) is reported. The bicyclic pyrimidine 2 starting material was prepared via a nitrilase biocatalytic resolution, halogen-metal exchange/anionic cyclization, and a highly diastereoselective biocatalytic ketone reduction as key steps. The route also features a halide activated, Ru-catalyzed asymmetric hydrogenation of a vinylogous carbamic acid to produce α-aryl-β-amino acid 3 in high yield and enantioselectivity. The API was assembled in a convergent manner through a late-stage amidation/deprotection/monohydrochloride salt formation sequence.

Asymmetric Hydrogenation of Quinoline Derivatives Catalyzed by Cationic Transition Metal Complexes of Chiral Diamine Ligands: Scope, Mechanism and Catalyst Recycling.

This personal account is focused on the asymmetric hydrogenation of quinolines and their analogues recently developed by using phosphorus-free chiral cationic ruthenium(II)/η6 -arene-N-monosulfonylated diamine complexes. In our initial study, the chiral Ru-diamine complexes were found to be highly effective catalysts for the asymmetric hydrogenation of difficult quinoline substrates in room temperature ionic liquids (RTILs) with unprecedentedly excellent enantioselectivity. Our further systematic study revealed that a wide range of quinoline derivatives could be efficiently hydrogenated in alcoholic solvents, or under solvent-free and concentrated conditions with good to excellent stereoselectivity. Complexes of iridium analogues could also efficiently catalyze the asymmetric hydrogenation of quinolines in undegassed solvent. Asymmetric tandem reduction of various 2-(aroylmethyl)quinolines was achieved in high yield with excellent enantioselectivity and good diastereoselectivity. More challenging substrates, alkyl- and aryl-substituted 1,5- and 1,8-naphthyridine derivatives were successfully hydrogenated with these chiral ruthenium catalysts to give 1,2,3,4-tetrahydronaphthyridines with good to excellent enantioselectivity. Unlike the asymmetric hydrogenation of ketones, quinoline is reduced via a stepwise H+ /H- transfer process outside the coordination sphere rather than a concerted mechanism. The enantioselectivity originates from the CH/π attraction between the η6 -arene ligand in the Ru-complex and the fused phenyl ring of dihydroquinoline via a 10-membered ring transition state with the participation of TfO- anion. In addition, the Ru-catalyzed asymmetric hydrogenation of quinolines could be carried out in some environmentally benign reaction media, such as undegassed water, RTILs and oligo(ethylene glycol)s (OEGs). In the latter two cases, unique chemoselectivity and/or reactivity were observed. Catalyst recycling could also be realized by using [BMIM]PF6 and OEGs as solvents, as well as via magnetic nanoparticles. Applications of this catalytic protocol were also exemplified by the employments of the reduced products for the syntheses of some important natural alkaloids, pharmaceutical intermediates, as well as chiral diamine ligands.

Ru-Catalyzed Asymmetric Hydrogenation of Substituted 1,5-Naphthyridines

Key words ruthenium - asymmetric hydrogenation - heterocycles - 1,5-naphthyridines

ChemInform Abstract: Synthesis of Chiral Cyclic β‐Amino Ketones by Ru‐Catalyzed Asymmetric Hydrogenation.

Abstract Synthesis of chiral cyclic β-amino ketones has been first reported via Ru-catalyzed asymmetric hydrogenation. High enantioselectivities were achieved by using ( S )-C 3 -TunePhos chiral ligand (up to 94% ee).

A new class of tunable dendritic diphosphine ligands: synthesis and applications in the Ru-catalyzed asymmetric hydrogenation of functionalized ketones.

A series of tunable G0-G3 dendritic 2,2'-bis(diphenylphosphino)-1,1'-binaphthyl (BINAP) ligands was prepared by attaching polyaryl ether dendrons onto the four phenyl rings on the P atoms. Their ruthenium complexes were employed in the asymmetric hydrogenation of β-ketoesters, α-ketoesters, and α-ketoamides to reveal the effects of dendron size on the catalytic properties. The second- and third-generation catalysts exhibited excellent enantioselectivities, which are remarkably higher than those obtained from the small molecular catalysts and the first-generation catalyst. Molecular modeling indicates that the incorporation of bulky dendritic wedges can influence the steric environments around the metal center. In addition, the ruthenium catalyst bearing a second-generation dendritic ligand could be recycled and reused seven times without any obvious decrease in enantioselectivity.

ChemInform Abstract: Diastereo‐ and Enantioselective anti‐Selective Hydrogenation of α‐Amino‐β‐keto Ester Hydrochlorides and Related Compounds Using Transition‐Metal‐Chiral‐Bisphosphine Catalysts

AbstractReview: [28 refs.